Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 323, pseudogene (RN7SL323P)

Target
RN7SL323P
Molecular classification
Pseudogene, Non-coding RNA (misc RNA biotype)
01

Overview

RNA, 7SL, cytoplasmic 323, pseudogene (RN7SL323P) is a human non-coding RNA pseudogene derived from the 7SL RNA family, specifically mapping to chromosome 8q12.1[1][5]. The 7SL RNA gene encodes the RNA component of the signal recognition particle (SRP), which functions in directing protein trafficking to the endoplasmic reticulum[7]. However, RN7SL323P is a **pseudogene**—it is a non-functional remnant of 7SL RNA, likely produced by retrotransposition and not believed to generate a stable, functional RNA transcript[3]. Pseudogenes like RN7SL323P typically lack protein-coding potential and do not serve as classical molecular targets (receptors, enzymes, etc.). While recent research suggests that some pseudogenes may play roles in gene regulation (such as acting as competitive endogenous RNAs or sources of regulatory small RNAs), there is no evidence for a specific regulatory or disease-related function of RN7SL323P itself[4]. RN7SL323P is not considered a therapeutic target, biomarker, or safety concern in clinical settings.

Other names
RN7SL323PRNA, 7SL, cytoplasmic 323, pseudogene7SL RNA pseudogene (general family)
02

Biological functions

Other (acts as a non-coding pseudogene, no direct functional molecule/protein product)
03

Disease associations

Other (pseudogenes in the 7SL RNA family may participate in gene regulation, but there is no evidence of disease association for this specific pseudogene)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 323, pseudogene (RN7SL323P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 323, pseudogene (RN7SL323P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call